Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 6, 2013, Pages

  Ehsan, Afshin ^a   McGraw, Adam P ^a   Aronovitz, Mark J ^a   Galayda, Carol ^a   Conte, Michael S ^b   Karas, Richard H ^a   Jaffe, Iris Z ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PLACEBO; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; CELL INFILTRATION; CONTROLLED STUDY; FIBROSIS; GRAFT PATENCY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VEIN GRAFT;

EID: 84877806820     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.08.007     Document Type: Article

References (25)

1. R.M. Zwolak, M.C. Adams, and A.W. Clowes Kinetics of vein graft hyperplasia: association with tangential stress J Vasc Surg 5 1987 126 136
2. P. Parang, and R. Arora Coronary vein graft disease: pathogenesis and prevention Can J Cardiol 25 2009 e57 e62
3. A. Westerband, J.L. Mills, J.M. Marek, R.L. Heimark, G.C. Hunter, and S.K. Williams Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses J Vasc Surg 25 1997 64 73
4. M. Hosono, M. Euda, S. Suehiro, Y. Sasaki, T. Shibata, and K. Hattori Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis J Thorac Cardiovasc Surg 120 2000 319 328
5. S.P. Salzberg, F. Filsoufi, A. Anyanwu, H.K. von, E. Karlof, and A. Carpentier Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes Circulation 114 2006 I302 I307
6. A. McCurley, and I.Z. Jaffe Mineralocorticoid receptors in vascular function and disease Mol Cell Endocrinol 350 2012 256 265
7. I.Z. Jaffe, and M.E. Mendelsohn Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cells Circ Res 96 2005 643 650
8. I.Z. Jaffe, B.G. Newfell, M. Aronovitz, N.N. Mohammad, A.P. McGraw, and R.E. Perrault Placental growth factor mediates aldosterone-dependent vascular injury in mice J Clin Invest 120 2010 3891 3900
9. R. Bafford, X.X. Sui, M. Park, T. Miyahara, B.G. Newfell, and I.Z. Jaffe Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization Am J Phys Heart Circ Phys 301 2011 H41 H47
10. R.H. Karas, B.L. Patterson, and M.E. Mendelsohn Human vascular smooth muscle cells contain functional estrogen receptor Circulation 89 1994 1943 1950
11. B.G. Newfell, L.K. Iyer, N.N. Mohammad, A.P. McGraw, A. Ehsan, and G. Rosano Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways Arterioscler Thromb Vasc Biol 31 2011 1871 1880
12. C.E. Gomez-Sanchez, A.F. de Rodriguez, D.G. Romero, J. Estess, M.P. Warden, and M.T. Gomez-Sanchez Development of a panel of monoclonal antibodies against a mineralocorticoid receptor Endocrinology 147 2006 1343 1348
13. L.A. Cassis, M.J. Helton, D.A. Howatt, V.L. King, and A. Daugherty Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms Br J Pharmacol 144 2005 443 448
14. T.R. Sullivan Jr., R.H. Karas, M. Aronovitz, G.T. Faller, J.P. Ziar, and J.J. Smith Estrogen inhibits the response-to-injury in a mouse carotid artery model J Clin Invest 96 1995 2482 2488
15. R.S. Vasan, J.C. Evans, M.G. Larson, P.W.F. Wilson, J.B. Meigs, and N. Rifai Serum aldosterone and the incidence of hypertension in nonhypertensive persons N Engl J Med 351 2004 33 41
16. G.D. Angelina, A.J. Bryan, H.M. Williams, A.A. Soyombo, A. Williams, and J. Tovey Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation J Thorac Cardiovasc Surg 103 1992 1093 1103
17. C.D. Owens, F.J. Rybicki, N. Wake, A. Schanzer, D. Mitsouras, and M.D. Gerhard-Herman Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation J Vasc Surg 47 2008 1235 1242
18. F. Ivanes, S. Susen, F. Mouquet, P. Pigny, F. Cuilleret, and K. Sautiere Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure Eur Heart J 33 2012 191 202
19. P. Yu, B.T. Nguyen, M. Tao, C. Campagna, and C.K. Ozaki Rationale and practical techniques for mouse models of early vein graft adaptations J Vasc Surg 52 2010 444 452
20. P.M. McGah, D.F. Leotta, K.W. Beach, R.E. Zierler, J.J. Riley, and A. Aliseda Hemodynamic conditions in a failing peripheral artery bypass graft J Vasc Surg May 1, 2012 [Epub ahead of print]
21. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
22. H. Tatewaki, K. Egashira, S. Kimura, T. Nishida, S. Morita, and R. Tominaga Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation J Vasc Surg 45 2007 1236 1243
23. K. Ohtani, K. Egashira, Y. Ihara, K. Nakano, K. Funakoshi, and G. Zhao Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells Hypertension 48 2006 664 670
24. A. Ehsan, M.J. Mann, G. Dell'Acqua, and V.J. Dzau Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy J Thorac Cardiovasc Surg 121 2001 714 722
25. A. Schepers, M.R. de Vries, C.J. van Leuven, J.M. Grimbergen, V.M. Holers, and M.R. Daha Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice Circulation 114 2006 2831 2838